← Every company

Eli Lilly and Co SEC Filings

What Eli Lilly and Co has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

LLY overview →
Filings on file
135
since Oct 25, 2016
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Nov 21, 2025
Executive or director change
8-K
Read ↗
Nov 19, 2024
Executive or director change
8-K
Read ↗
Sep 9, 2024
Executive or director change
8-K
Read ↗
Aug 16, 2024
Executive or director change
8-K
Read ↗
Jul 10, 2024
Executive or director change
8-K
Read ↗
Jun 5, 2024
Executive or director change
8-K
Read ↗
Mar 17, 2023
Executive or director change
8-K
Read ↗
May 6, 2022
Executive or director change
8-K
Read ↗
Aug 25, 2021
Executive or director change
8-K
Read ↗
Aug 17, 2021
Executive or director change
8-K
Read ↗
Feb 17, 2021
Executive or director change
8-K
Read ↗
Feb 9, 2021
Executive or director change
8-K
Read ↗
Jan 14, 2021
Executive or director change
8-K
Read ↗
Oct 23, 2019
Executive or director changeResults announced
8-K
Read ↗
Jul 11, 2019
Executive or director change
8-K
Read ↗
Oct 16, 2018
Executive or director change
8-K
Read ↗
May 11, 2018
Executive or director change
8-K
Read ↗
Jan 31, 2018
Executive or director changeResults announced
8-K
Read ↗
Jun 1, 2017
Executive or director change
8-K
Read ↗
Feb 9, 2017
Executive or director change
8-K
Read ↗

Source: Eli Lilly and Co's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on LLY

Related datasets